What does PHARMACIE DUVAL do?

PHARMACIE DUVAL is a pharmacy in Verviers. Private Limited, started on 26 December 2006, 1 establishment.

What is the address of PHARMACIE DUVAL?

The registered office of PHARMACIE DUVAL is located at Pont aux Lions 13, 4800 Verviers.

Is PHARMACIE DUVAL still active?

Yes. According to the CBE (1 October 2026) PHARMACIE DUVAL is active, legal situation “Normale toestand”, started on 26 December 2006.

Is PHARMACIE DUVAL registered on Peppol?

Yes, PHARMACIE DUVAL is registered on the Peppol network with ID 0208:0885923071.

What is the enterprise number of PHARMACIE DUVAL?

The enterprise number of PHARMACIE DUVAL is BE0885923071.

When was PHARMACIE DUVAL founded?

PHARMACIE DUVAL was founded on 26 December 2006.

Who are the directors of PHARMACIE DUVAL?

According to the 2025 annual accounts, the directors of PHARMACIE DUVAL are: Françoise DUVAL.

Is PHARMACIE DUVAL a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 26 December 2006; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did PHARMACIE DUVAL make in 2025?

PHARMACIE DUVAL posted a profit after taxes of € 15,039 in financial year 2025.

What is the revenue of PHARMACIE DUVAL?

As a small company, PHARMACIE DUVAL is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 53,452.

PHARMACIE DUVAL (Private Limited) - Verviers

Dossier PHARMACIE DUVAL, printed on 1 October 2026 from databakkes.be/en/0885923071/pharmacie-duval. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Tight liquidity NBB

Cash and receivables cover 30 % of short-term debt in 2025; threshold 65 %.

Financials

Financial year 2025

PHARMACIE DUVAL from Verviers, company number BE0885923071, closed financial year 2025 with a result of € 15,039 after tax. For that financial year PHARMACIE DUVAL recorded a gross margin of € 53,452 and equity of € 76,581. Compared with financial year 2024, the result moved from € 16,373 to € 15,039. The company is profitable. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on August 28, 2026.

What it is worth Growing

€ 76,581

▲ 9% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 15,039

▼ 8% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 30,059

▲ 255% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 8,833 paid out

59 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Vehicles and equipment

€ 4,162

▼ 51% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 1 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 144,443

▲ 8% vs 2024

€ 19,103 is repaid this year. At this pace the long-term loan is gone in ≈ 1 years.

Owed to suppliers

€ 88,513

▼ 3% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 20,771

▲ 69% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 43,368 Gross margin 2022: € 43,368 First fiscal year in the series	€ 37,225 Gross margin 2023: € 37,225 ▼ 14% vs 2022 (€ 43,368) Unfavourable step	€ 65,774 Gross margin 2024: € 65,774 ▲ 77% vs 2023 (€ 37,225) Favourable step	€ 53,452 Gross margin 2025: € 53,452 ▼ 19% vs 2024 (€ 65,774) Unfavourable step	▼ 19%
Profit after taxes	€ 1,981 Profit after taxes 2022: € 1,981 First fiscal year in the series	€ -3,524 Profit after taxes 2023: € -3,524 ▼ € 5,505 vs 2022 (€ 1,981) Unfavourable step	€ 16,373 Profit after taxes 2024: € 16,373 ▲ € 19,897 vs 2023 (€ -3,524) Favourable step	€ 15,039 Profit after taxes 2025: € 15,039 ▼ 8% vs 2024 (€ 16,373) Unfavourable step	▼ 8%
Equity	€ 58,359 Equity 2022: € 58,359 First fiscal year in the series	€ 54,835 Equity 2023: € 54,835 ▼ 6% vs 2022 (€ 58,359) Unfavourable step	€ 70,375 Equity 2024: € 70,375 ▲ 28% vs 2023 (€ 54,835) Favourable step	€ 76,581 Equity 2025: € 76,581 ▲ 9% vs 2024 (€ 70,375) Favourable step	▲ 9%
Total debts	€ 342,718 Total debts 2022: € 342,718 First fiscal year in the series	€ 304,924 Total debts 2023: € 304,924 ▼ 11% vs 2022 (€ 342,718) Favourable step	€ 286,649 Total debts 2024: € 286,649 ▼ 6% vs 2023 (€ 304,924) Favourable step	€ 301,831 Total debts 2025: € 301,831 ▲ 5% vs 2024 (€ 286,649) Unfavourable step	▲ 5%
Cash	€ 21,274 Cash 2022: € 21,274 First fiscal year in the series	€ 12,814 Cash 2023: € 12,814 ▼ 40% vs 2022 (€ 21,274) Unfavourable step	€ 8,473 Cash 2024: € 8,473 ▼ 34% vs 2023 (€ 12,814) Unfavourable step	€ 30,059 Cash 2025: € 30,059 ▲ 255% vs 2024 (€ 8,473) Favourable step	▲ 255%
Land & buildings	€ 233,534 Land & buildings 2022: € 233,534 First fiscal year in the series	€ 221,996 Land & buildings 2023: € 221,996 ▼ 5% vs 2022 (€ 233,534) Unchanged	€ 210,459 Land & buildings 2024: € 210,459 ▼ 5% vs 2023 (€ 221,996) Unchanged	€ 198,921 Land & buildings 2025: € 198,921 ▼ 5% vs 2024 (€ 210,459) Unchanged	▼ 5%
Retained profit	€ 39,759 Retained profit 2022: € 39,759 First fiscal year in the series	€ 36,235 Retained profit 2023: € 36,235 ▼ 9% vs 2022 (€ 39,759) Unfavourable step	€ 51,775 Retained profit 2024: € 51,775 ▲ 43% vs 2023 (€ 36,235) Favourable step	€ 57,981 Retained profit 2025: € 57,981 ▲ 12% vs 2024 (€ 51,775) Favourable step	▲ 12%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 0 Dividend 2023: € 0 Unchanged (€ 0) Unchanged	€ 833 Dividend 2024: € 833 Unchanged (€ 0) Unchanged	€ 8,833 Dividend 2025: € 8,833 ▲ € 8,000 vs 2024 (€ 833) Unchanged	▲ € 8,000
Bank debt	€ 141,676 Bank debt 2022: € 141,676 First fiscal year in the series	€ 159,611 Bank debt 2023: € 159,611 ▲ 13% vs 2022 (€ 141,676) Unfavourable step	€ 133,488 Bank debt 2024: € 133,488 ▼ 16% vs 2023 (€ 159,611) Favourable step	€ 144,443 Bank debt 2025: € 144,443 ▲ 8% vs 2024 (€ 133,488) Unfavourable step	▲ 8%
Balance sheet total	€ 401,077 Balance sheet total 2022: € 401,077 First fiscal year in the series	€ 359,760 Balance sheet total 2023: € 359,760 ▼ 10% vs 2022 (€ 401,077) Unchanged	€ 357,023 Balance sheet total 2024: € 357,023 ▼ 1% vs 2023 (€ 359,760) Unchanged	€ 378,412 Balance sheet total 2025: € 378,412 ▲ 6% vs 2024 (€ 357,023) Unchanged	▲ 6%
Employees (FTE)	0.1 Employees (FTE) 2022: 0.1 First fiscal year in the series	-	-	-

Key figures of PHARMACIE DUVAL, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to PHARMACIE DUVAL?

What happened at PHARMACIE DUVAL in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 28, 2026 New annual accounts for financial year 2025: profit of € 15,039 (▼ 8% vs 2024). filed late Source: NBB ↗
Dec 29, 2006 New establishment in Verviers. KBO
Dec 26, 2006 Start of the company according to the CBE. KBO

In short

From € 1,981 profit in 2022 to € 15,039 profit in 2025.

Paid € 19,428 in corporate taxes since 2022.

Best year ever: 2024, with € 16,373 profit.

Paid out € 9,666 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at PHARMACIE DUVAL? We notify you, reason included.

Follow PHARMACIE DUVAL

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Françoise DUVAL

PHARMACIE DUVAL

Behind PHARMACIE DUVAL is Françoise DUVAL.

See the full network in the app

Directors

According to the 2025 annual accounts

Françoise DUVAL

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Pont aux Lions 13

4800 Verviers

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0885.923.071

VAT number

BE 0885.923.071

Registered office

Pont aux Lions 13, 4800 Verviers

Names & denominations

PHARMACIE DUVAL

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

26 December 2006

Peppol

Active · Active since 9 Dec 2025

Activities · NACE

Detailhandel in farmaceutische producten

Apothekers

View on CBE Public ↗ Annual accounts (NBB) ↗

PHARMACIE DUVAL

Warning lights

Financials

What happened to PHARMACIE DUVAL?

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Management

Directors

Establishments

Establishment units

Details

Frequently asked questions